Clinical Trials
18 trialsNCT04038502 2025-08-20
COBRA
VA Office of Research and Development
Phase 2 Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT00060398 2023-06-15
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT04425200 2021-12-07
ZENSHIN
AstraZeneca
Completed
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT03006562 2020-08-05
PREVENTER
Johns Hopkins University
Phase 4 Terminated
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT01286987 2019-01-10
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Pfizer
Phase 1 Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT01325558 2016-07-15
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
Phase 1 Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT00381836 2015-12-04
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
University of Aarhus
Phase 2/3 Terminated
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT00899665 2014-02-11
Proteases in Patients With Prostate Cancer That Has Spread to the Bone
Barbara Ann Karmanos Cancer Institute
Completed
NCT00270166 2011-05-18
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3 Completed
NCT00245895 2007-11-29
Study of Aranesp to Treat Anemia in Prostate Cancer Patients.
University of Washington
Phase 2 Completed